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Abstract
Background: Salvianolic acid B (SB) is an active component isolated from Danshen, a traditional Chinese medicine widely
used for the treatment of cardiovascular disorders. Previous study suggested that SB might inhibit adhesion as well as
aggregation of platelets by a mechanism involving the integrin a2b1. But, the signal cascades in platelets after SB binding
are still not clear.
Methodology/Principal Findings: In the present study, a differential proteomic analysis (two-dimensional electrophoresis)
was conducted to check the protein expression profiles of rat platelets with or without treatment of SB. Proteins altered in
level after SB exposure were identified by MALDI-TOF MS/MS. Treatment of SB caused regulation of 20 proteins such as heat
shock-related 70 kDa protein 2 (hsp70), LIM domain protein CLP-36, copine I, peroxiredoxin-2, coronin-1 B and cytoplasmic
dynein intermediate chain 2C. The regulation of SB on protein levels was confirmed by Western blotting. The signal
cascades network induced by SB after its binding with integrin a2b1 was predicted. To certify the predicted network,
binding affinity of SB to integrin a2b1 was checked in vitro and ex vivo in platelets. Furthermore, the effects of SB on protein
levels of hsp70, coronin-1B and intracellular levels of Ca(2+) and reactive oxygen species (ROS) were checked with or
without pre-treatment of platelets using antibody against integrin a2b1. Electron microscopy study confirmed that SB
affected cytoskeleton structure of platelets.
Conclusions/Significance: Integrin a2b1 might be one of the direct target proteins of SB in platelets. The signal cascades
network of SB after binding with integrin a2b1 might include regulation of intracellular Ca(2+) level, cytoskeleton-related
proteins such as coronin-1B and cytoskeleton structure of platelets.
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Introduction
Salvianolic acid B (SB) is one of the main components of Danshen
(root of Salvia miltiorrhiza), a popularly used traditional Chinese
medicine for patients with coronary artery disease in both China and
other countries including the U.S. [1-4]. The mechanism of Danshen
is still not clear but its inhibitive effect on platelet adhesion and
aggregation might be one of the important bases for its cardiovascular
effects. Both crude extract of Danshen [5-7] and purified compounds
such as SB [8,9] were reported to exhibit inhibitory effects on platelet
aggregation and adhesion. Our previous study also showed that
salvianolic acids isolated from Salvia miltiorrhiza could inhibit ADP-
induced platelet aggregation of rat platelets both in vitro and ex vivo
[10]. Furthermore, our cooperation study result suggested that SB
might inhibit platelet adhesion by a mechanism involving the integrin
a2b1 (collagen receptor a2b1) [9].
To further clarify the signal cascades in SB-treated platelets, a
proteomic approach was used in the present study to identify
regulated proteins after exposure of intact platelets to SB. The result
of proteomic analysis was confirmed by using Western blotting assay.
And, comparing with our previous proteomic study using a mixture
of salvianolic acids [11], the results suggested that the most important
target-related proteins of SB might be heat shock-related 70 kDa
protein 2, LIM domain protein CLP-36, copine I, peroxiredoxin-2,
coronin-1 B and cytoplasmic dynein intermediate chain 2C. The
possible signal cascades net work in platelets after binding of SB to
integrin a2b1 was predicted. To certify the predicted network, the
binding affinity of SB to integrin a2b1 waschecked both invitroand ex
vivo in platelets. Furthermore, the effects of SB on platelets such as
changing protein levels and changing intracellular Ca (2+) level, ROS
level as well as cell size were observed with or without pre-treatment
of platelets using an antibody against integrin a2b1.
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Effect of SB on platelet adhesion and aggregation
As shown in B of Fig. 1, SB dose-dependently inhibited the
adhesion of platelets on collagen. And, as shown in C of Figure 1,
SB also could dose-dependently inhibit the aggregation of platelets
induced by collagen.
Protein expression profiles of platelets and identification
of the differentially expressed proteins
Representative two-dimensional electrophoresis gel images for
control, SB-treated platelets were shown in A of Fig. 2. Fifteen up-
regulated protein spots and five down-regulated protein spots was
found as indicated by the arrowed spots in A of Fig. 2 and by the
expanded plots in B of Fig. 2. Table S1 showed the average
intensity values and their standard deviations of the spots and the
fold differences between control and SB-treated group. The fold
difference was represented by the ratio of the intensity value of SB-
treated group to the value of control group. MS/MS analysis
results of the differentially expressed proteins were also summa-
rized in Table S1. The protein score, coverage and best ion score
of each protein were showed. The result of MALDI-TOF MS/MS
analysis of spot 4 was shown in Fig. 3 as an example.
Confirmation of change in expression level and
phosphorylation of proteins by Western blotting
As shown in Fig. 4, hsp 70 protein was up-regulated in SB-
treated platelets and, more importantly, phosphorylated hsp 70
level was also obviously up-regulated. Besides, 14-3-3E was found
to be down-regulated while guanine nucleotide binding protein
beta subunit and coronin-1B were found to be up-regulated in SB-
treated platelets. These results were consistent with the proteomic
result.
Possible signal cascades network in platelets after
binding of SB
In our previous proteomic study, the effect of a mixture of
salvianolic acids on the protein expression profile of platelets was
checked and 12 differentially expressed proteins were found [11].
By comparing the 12 proteins found in the previous study with the
20 proteins found in the present study, we could identify 6 proteins
that appeared in the both studies. They were heat shock-related 70
kDa protein 2 (heat shock protein 2), LIM domain protein CLP-
36, copine I, peroxiredoxin-2, coronin-1 B and cytoplasmic dynein
intermediate chain 2C. Interestingly, these 6 proteins were closely
related to integrin a2b1, the possible direct target protein of SB
identified in our previous study [9]. The possible signal cascades
network in platelets after binding of SB to integrin a2b1 was
predicted (A of Fig. 5). After binding to integrin a2b1, SB might
induce regulation of its un-direct target-related protein through
direct activation (heat shock protein 2), regulation of Ca(2+) level
(copine I), ROS level (peroxiredoxin-2) and reorganization of
cytoskeleton structure (LIM domain protein CLP-36, coronin-1 B
and cytoplasmic dynein intermediate chain 2C).
Certification of binding affinity of SB to integrin a2b1 in
vitro and ex vivo
To verify the prediction that SB could bind directly to integrin
a2b1 protein, the binding affinity of SB towards integrin a2b1 in
vitro was determined by using Surface Plasmon Resonance (SPR)
Biosensor analysis. The binding ability of SB towards integrin a2-I
domain was reflected by response unit (RU) values recorded by the
Biacore 3000 instrument. As shown in C of Fig. 5, RU increased
with increasing SB concentration, which indicated that SB was
able to bind to integrin a2-I in a dose-dependent manner. Binding
of SB to integrin a2-I exhibited steady state. The equilibrium
dissociation (KD) constant of SB binding to the immobilized
integrin a2-I was 442610
26 [M]. The curve fitting efficiency was
evaluated by statistical parameter Chi
2, a statistical parameter in
SPR assay. The Chi
2 value was calculated to be 2.28.
The binding affinity of SB to integrin a2b1 located on platelets
was checked ex vivo in platelets. As shown in D of Fig. 5, a FITC-
conjugated antibody against integrin a2b1 could bind to platelets
and exhibited FITC fluorescence in flow cytometry analysis. Co-
incubation of SB and the antibody with platelets could significantly
Figure 1. The inhibitive effect of SB on platelet adhesion and
platelet aggregation. A, chemical structure of SB. B, SB dose-
dependently inhibited adhesion of rat washed platelets. C, SB dose-
dependently inhibited aggregation of rat platelets induced by collagen.
Data represent mean 6 S.D. (n=6). *Significant difference from the
control group at P,0.05.
doi:10.1371/journal.pone.0014692.g001
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was indicated by decrease in FITC fluorescence values of platelets.
The results suggested that SB could compete with the antibody for
the binding site of integrin a2b1 on platelets.
Checking the effects of SB on platelets with or without
pre-treatment of antibody against integrin a2b1
To confirm whether SB-caused changes in protein levels,
intracellular Ca(2+) level, ROS level and cell size were dependent
on its binding with integrin a2b1, the protein levels of coronin-1 B,
hsp70, p-hsp70 and the intracellular Ca(2+) level, ROS level, cell
size were checked in platelets with or without pre-treatment of
antibody against integrin a2b1. As shown in E of Fig. 5, pre-
treatment of antibody against integrin a2b1 blocked the increase
of coronin-1 B but did not affect the increase of hsp70 as well as
that of p-hsp70 caused by SB. The results indicated that the
increase of coronin-1 B might be dependent on binding of SB with
integrin a2b1. As shown in F of Fig. 5, the fact that antibody
treatment alone could induce decrease of intracellular Ca(2+) level
indicated that binding of integrin directly cause change in Ca(2+)
equilibrium. In platelets treated with both antibody and SB, the
decrease of intracellular Ca(2+) level might be result from
combination of the effects of antibody and SB. On the contrary,
antibody against integrin a2b1 showed no effect on ROS level and
also no effect on SB-caused ROS level decrease (G of Fig. 5). The
results indicated that the effect of SB on ROS might not be
dependent on integrin a2b1. For the cell size, as shown in H of
Fig. 5, though antibody alone did not induce significant change in
Figure 2. The proteome maps of control and SB-treated platelets. A, Representative two-dimensional electrophoresis gel pair images.
Differentially expressed spots were shown by the arrows. B, The expanded region of differentially expressed protein spots in A. The proteins within
the circles were the differentially expressed proteins.
doi:10.1371/journal.pone.0014692.g002
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effect of SB on cell size.
According to above results, the predicted signal network was
revised. The revised network of SB after binding with integrin
a2b1 was shown in B of Fig. 5.
Effect of SB on cytoskeleton structure of platelets
Since the signal network suggested that SB might affect
cytoskeleton structure and SB caused decrease in cell size as
showed in flow cytometry analysis, further study using electron
microscopic examination was conducted to check the effect of SB
on platelets. As shown in A of Fig. 6, SB did induce change of cell
shape in platelets. The control platelets was round or oval discoid
while part of the platelets change to more slim shape like spindle-
shaped after 100 mM SB treatment. Statistical analysis of the
percentage of platelets with spindle-like shape in total platelets
(result from 10 fields of view of 3 different experiments) indicated
that the change in the shape of platelets after SB treatment was
significant (B of Fig. 6).
Discussion
In the present study, SB was found to inhibit the adhesion and
aggregation of platelets induced by collagen. The effect of SB might
be related to its binding to integrin a2b1, the possible direct target
protein of SB found in our previous study [9]. The un-direct target-
related proteins of SB in platelets were searched in the present study
using a differential proteomic study. Proteomic technology has
become an indispensable and efficient tool in biochemical research.
And, this technology has successfully used to study signal pathways in
platelets [12,13]. Twenty possible target-related proteins of SB in
platelets were found in the present study. Among the 20 proteins, 6
Figure 3. The result of the MALDI-TOF MS/MS analysis of the protein spot 4. It was identified to be rat 14-3-3 epsilon (NCBI accession
number 13928824) by protein database search. A, Peptide mass fingerprint of the tryptic digest of spot 4. Peptide signals identified were marked with
asterisks. B, MS/MS profile of the peptide with a mass of 2331.21 Da. y-ions resulting from fragmentation of the peptides and amino acids they
represent are indicated.
doi:10.1371/journal.pone.0014692.g003
Figure 4. Results of Western blotting analysis. Protein levels of
hsp 70, p-hsp70, guanine nucleotide binding protein beta, 14-3-3E and
coronin-1B were checked. Each blot is the representative result of three
independent experiments.
doi:10.1371/journal.pone.0014692.g004
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protein 2), LIM domain protein CLP-36, copine I, peroxiredoxin-2,
coronin-1 B and cytoplasmic dynein intermediate chain 2C might be
the most important ones and have close relationship with integrin
a2b1 binding. The possible signal cascades network in platelets after
binding of SB to integrin a2b1 was predicted based on previous
reports and protein-protein interaction database. For example,
previous works indicated that integrin a2b1 binding could cause
change in calcium homeostasis and calcium-dependent functions
[14,15]. Previous report also suggested that, by binding to integrin
a2b1, endorepellin could trigger transient activation of p38 mitogen-
activated protein kinase (MAPK) and heat shock protein 27 and
ultimately disassembly of actin stress fibers and focal adhesions [16].
To certify the predicted signal network, both the binding affinity
of SB to integrin a2b1 and the influence of pretreatment with
antibody against integrin a2b1 on the effects of SB in platelets
were checked. The results indicated that SB had dose-dependently
binding affinity to integrin a2b1 in vitro and could compete with
antibody against integrin a2b1 for the binding site of integrin
a2b1 on the membrane of platelets. Furthermore, flow cytometry
analysis result confirmed that SB treatment caused dose-
dependently decrease in intracellular level of Ca(2+) level and
the effect of SB on Ca(2+) level might be related to integrin a2b1
binding. And, the change in coronin-1 B protein level caused by
SB treatment was also dependent on integrin a2b1 binding. The
revised signal network of SB including binding with integrin a2b1,
change in Ca(2+) level, reorganization of cytoskeleton as well as
change in cytoskeleton-related proteins such as coronin-1 B was
established. As to the SB-caused change in ROS level and heat
shock protein 70 level, our results indicated that these effects of SB
might not be dependent on binding with integrin a2b1. For
example, the decrease in ROS might be caused by the potency of
SB to act as direct ROS scavenger. Based on its chemical structure
characteristic, SB could exhibit direct antioxidative effect in vitro as
well as in vivo [17,18].
In the present study, SB was found to induce change in
cytoskeleton of platelets. The flow cytometry analysis result
showed that SB treatment caused decrease in platelet size and
the scanning electron microscopic examination showed that SB
treatment caused change in platelet shape. The change in
cytoskeleton of platelets might be related to change in intracellular
Ca(2+) level and subsequent regulation of proteins including
copine I, coronin-1B, LIM domain protein CLP-36 and
cytoplasmic dynein intermediate chain 2C. Copine I belongs to
a ubiquitous family of calcium-dependent, membrane-binding
proteins. In response to changes in intracellular Ca(2+), copines
might regulate the activities and localization of their target
proteins such as MEK1 [19,20]. Previous reports suggested that
integrin a2b1 binding caused reorganization of cytoskeleton in
platelets [21,22] through MAPK pathway [23,24]. Coronins are a
conserved family of WD repeat-containing, actin-binding proteins
involved in modulating actin dynamics and cell motility [25,26].
SB-induced increase in coronin-1 B in platelets was showed to be
dependent on integrin a2b1 binding in the present study. LIM
domain protein CLP-36 is a cytoskeletal and anchoring protein
that has been suggested to be closely related to the plasma
membrane Ca(2+)-ATPase, which plays an essential role in
maintaining cytosolic Ca(2+) level in platelets [27]. Cytoplasmic
dynein intermediate chain 2C is a component of the complex
microtubule-based system of motor proteins in platelet [28].
In all, the present study identified 20 target-related proteins of
SB in platelets through proteomic analysis. Signal network of SB
from binding to its direct target integrin a2b1 was predicted and
then certified. Binding of SB to integrin a2b1 caused change in
level of intracellular Ca(2+), level of cytoskeleton-related proteins
Figure 6. Effect of SB treatment on the shape of platelets. A,
Representative result of scanning electron microscopy analysis. (a),
Magnification 1000X, scale bar=20 mm. (b), Higher magnification views
of the boxed fields in (a), magnification 6000X, scale bar=5 mm. (c)
Higher magnification views of the boxed fields in (b), magnification
12000X, scale bar=2 mm. B, The percentage of platelets with spindle-
like shape in total platelets (result from 10 fields of view of 3 different
experiments). *Significant difference from the control group at P,0.05.
doi:10.1371/journal.pone.0014692.g006
Figure 5. Prediction and certification of signal network of SB after binding with integrin a2b1. A. Predicted signal network of SB. The red
dot illustrates integrin a2b1 while the blue dots are un-direct target-related proteins found in the proteomic study. The intermediate partners are
shown in grey. B. Revised signal network of SB. C. Real time binding affinity measurement of SB to the integrin a2-I protein in vitro using Biacore 3000.
Representative sensorgrams were obtained from injections of SB at concentrations of 16.8, 24, 34.3, 49, 70 and 100 mM (curves from bottom to top)
over the immobilized integrin a2-I surface. D. Influence of SB treatment on binding between integrin a2b1 on platelets and its specific FITC-
conjugated antibody. Both representative flow cytometry analysis result and quantitative results were shown. E. Western blotting analysis of protein
levels of coronin-1 B, hsp70 and p-hsp70 in platelets under SB treatment with or without pretreatment of antibody against integrin a2b1. F. Flow
cytometry analysis result of intracellular Ca(2+) level in platelets under SB treatment with or without pretreatment of antibody against integrin a2b1.
Both respresentative flow cytometry analysis result and quantitative results were shown. G. Flow cytometry analysis result of intracellular ROS level in
platelets under SB treatment with or without pretreatment of antibody against integrin a2b1. Both representative flow cytometry analysis result and
quantitative results were shown. H. Flow cytometry analysis result of cell size of platelets under SB treatment with or without pretreatment of
antibody against integrin a2b1. Both representative flow cytometry analysis result and quantitative results (FSC values) were shown. *Significant
difference from the control group at P,0.05, **Significant difference from the control group at P,0.01,
#Significant difference from the antibody
treatment group at P,0.05.
doi:10.1371/journal.pone.0014692.g005
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cascades after SB binding to integrin a2b1 might be important
basis for the inhibitive effect of SB on platelet adhesion and
aggregation. To date, this study is the first to employ the
proteomic technique to search globally for the proteins influenced
in platelets by SB. The result of proteomic analysis and the
suggested signal cascades network provided new hints for the study
of the mechanism of SB on platelets.
Materials and Methods
Materials and reagents
SB was isolated and purified from the roots of Salvia miltiorrhiza
by laboratory of phytochemistry, Shanghai Research Center for
Modernization of Traditional Chinese Medicine, Shanghai
Institute of Materia Medica, Chinese Academy of Sciences as
reported in our previous paper [28]. SB was dissolved in natural
saline for using in the following experiments. Natural saline was
used in the following experiments as solvent control. All reagents
used in two-dimensional electrophoresis were purchased from Bio-
Rad Laboratories (Hercules, CA, USA). Other chemicals, except
where specially noted, were purchased from Sigma-Aldrich
Chemical Co. (St. Louis, MO, USA).
Platelet preparation and adhesion assay
Platelet isolation was carried out as described previously [10].
Male SD rats (220–250 g) were bred and kept by the Laboratory
Animal Services Center of Shanghai Institute of Materia Medica,
Chinese Academy of Sciences. All procedures in animal
experiments were conducted according to protocol approved by
the Institutional Animal Care and Use Committee (IACUC) of
Shanghai Institute of Materia Medica, Chinese Academy of
Sciences. Platelet samples were permitted to be taken from
anesthetized SD rats (male) for further study. The permit number
for animal use in the present study is SIMM-AE-GDA-2010-02.
Rats were anesthetized with sodium pentobarbital (50 mg/kg,
i.p.). Blood samples were taken from the ventral aorta and
transferred into plastic tubes containing 3.8% trisodium citrate as
anticoagulant in a volume ratio 9:1. Platelet rich plasma was
obtained by centrifugation of blood at 200 6g for 10 min at room
temperature. To avoid contamination with red blood cells and
leukocytes, only the top one-third of platelet rich plasma was
collected. Platelet-poor plasma was obtained by centrifugation at
1700 6g for 10 min. Washed platelets were obtained by
centrifugation of platelet rich plasma at 1000 6g for 10 min and
then wash the platelets twice with Tyrode buffer (136 mM NaCl,
2.7 mM KCl, 12 mM NaHCO3, 0.42 mM NaH2PO4, 0.2 mM
MgSO4, 5.0 mM glucose) containing 0.2 mM EGTA, pH 6.5.
The washed platelets were then centrifuged again at 1000 6g for
10 min and finally re-suspended in Tyrode buffer with a cell
density of 3610
8 cells/ml. The contamination of red blood cells
and leukocytes were measured to be ,0.005% and ,0.02% (in
number), respectively.
Platelet adhesion assay was conducted similar to previous report
[29]. Briefly, microplate wells were coated with 50 mg/ml collagen
I (Sigma) overnight at 4 uC and washed twice with natural saline
before use. After incubated with natural saline or SB at different
concentrations at 37 uC for 5 min, 100 ml washed platelet
suspension was plated into each microplate well and then
incubated at 37 uC for 1 h in humidified thermostat. At the end
of incubation, the microplate wells were washed twice with PBS
and then rapidly supplemented with 150 ml of 0.1 M citrate buffer,
pH 5.4, containing 5 mM p-nitrophenyl phosphate and 0.1%
Triton X-100. After incubation at room temperature for 1 h, the
reaction was stopped and the color was developed by the addition
of 100 ml of 2 N NaOH. The p-nitrophenol produced by the
reaction was measured with a microplate reader (Bio-Rad) at
405 nm against a platelet-free blank.
Platelet aggregation assay was performed using collagen as the
aggregation inducer. Platelet rich plasma samples were obtained as
described above and diluted with platelet poor plasma to a cell
density of 3610
8 cells/ml. After incubated with natural saline or
SB at different concentrations at 37 uC for 5 min, platelet rich
plasma samples were put in silicone-treated glass cuvettes (200 ml/
each cuvette). Then, aggregation of platelets was induced by
addition of collagen (5 mg/ml) while stirring at 1000 rpm. The
reaction was then allowed to proceed for 5 min, and the peak
aggregation responses were measured using an aggregometer
(Model TYXN-96, TongYong Corp., Shanghai, P.R.China).
Proteomic analysis
Protein extraction. For protein sample preparation for
proteomic analysis, washed platelets were incubated for 10 min
with natural saline or 90 mM SB (dose of SB that is effective in
inhibition of both platelet adhesion and aggregation).
Subsequently, platelets were washed three times with PBS and
then centrifuged for 10 min at 2500 6 g. The pellets were
dissolved in lysis buffer containing 7 M urea, 2 M thiourea, 2%
CHAPS and 1% DTT, 0.8% Pharmalyte and protease-inhibitor
(all from Bio-Rad). Homogenization of the cells was achieved by
ultrasonication (10 strokes, low amplitude) on ice. The lysed cells
were centrifuged at 15000 6 g for 30 min at 4 uC and the
supernatant containing the solubilized proteins was used for two-
dimensional electrophoresis.
Two-dimensional electrophoresis
Two-dimensional electrophoresis was carried out similar to our
previous report [30] using Bio-Rad 2-DE system. Briefly, 150 mg
protein sample was applied for IEF using the ReadyStrip IPG
Strips, 17 cm, pH 4–7 (Bio-Rad). The strips were placed into a
Protein IEF cell (Bio-Rad) and were rehydrated at 50 V for 12 h
and then the proteins were separated based on their pI. After IEF,
the IPG strips were equilibrated and then directly applied on to
12% homogeneous SDS-PAGE gels for electrophoresis using a
PROTEIN II xi Cell system (Bio-Rad). The gels were then silver
stained using Silver Stain Plus kit reagents (Bio-Rad).
Differential image analysis
The silver-stained gels were scanned using a Densitometer GS-
800 (Bio-Rad) and then analyzed using PD-Quest software (Bio-
Rad). Comparisons were made between gel images of protein
profiles obtained from SB-treated group and control group. The
individual protein spot quantity was normalized as follows: the raw
quantity of each spot in a member gel was divided by the total
quantity of the valid spots in the gel, and normalized spot
intensities were expressed in ppm. Quantitative analysis was
performed using the Student’s t-test between protein gels from
control and SB-treated group. The significantly differentially
expressed protein spots (p,0.05) with two fold or more increased
or decreased intensity between control and SB-treated group were
selected and subjected to further identification by MALDI-TOF
MS/MS.
In-gel digestion, peptide extraction and MALDI-TOF MS/
MS
Proteins of interest were excised from the gels with EXQuest
Spot Cutter (Bio-Rad) and placed into a 96-well microtitre plate.
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pieces were de-stained, shrunk by dehydration in ACN and then
digested with trypsin. Peptides were then extracted twice using
0.1% TFA in 50% ACN and the extracts were dried under the
protection of N2. For MALDI-TOF MS/MS, peptides were mixed
with 0.7 ml MALDI matrix and spotted on to the 192-well MALDI
target plates. MS analysis was performed with an ABI 4700
Proteomics Analyzer MALDI-TOF/TOF mass spectrometer
(Applera Applied Biosystems, Framingham, MA, USA). Mass
spectra were obtained in a mass range of 700–3200 Da, using a
laser (355 nm, 200 Hz) as desorption ionization source. After MS
acquisition, the top five most intense peptides per spot were selected
automatically for the MS/MS analysis, i.e., sequencing of these
peptides. MS accuracy was externally calibrated with trypsin-
digested peptides of horse myoglobin. The database search was
performed by using the MASCOT search engine (Matrix Science,
London, United Kingdom) to screen the NCBI protein sequence
database restricted to rat taxonomy. Protein homology identifica-
tions of the top hit (first rank) with a relative score exceeding 95%
probability and additional hits (second rank or more) with a
relative score exceeding 98% probability threshold were retained.
The probability-based score, assuming that the observed match is
significant (P,0.05), had to be more than 50 when submitting
PMF data to the database, and be more than 30 for individual
peptide ions when submitting peptide sequence spectra.
Western blotting analysis
Briefly, an aliquot (50 mg) of the extracted platelet protein
samples was loaded onto a 12% SDS gel, separated electropho-
retically, and transferred to a PVDF membrane (Bio-Rad). After
blocking nonspecific protein binding with 10% dehydrated skim
milk, the membrane was incubated with primary antibodies
overnight at 4 uC. The primary antibodies used were mouse anti-
Hsp70 (5A5) monoclonal antibody (1:200, Abcam, Cambridge,
UK), rabbit anti-p-Hsp70 (Tyr 525) polyclonal antibody (1:200,
Santa Cruz Biotechnology, California, CA, USA), goat anti-
coronin 1B (C-19) polyclonal antibody (1:250, Santa Cruz
Biotechnology, California, CA, USA), chicken anti-guanine
nucleotide binding protein beta subunit polyclonal antibody
(1:300, United States Biological, Massachusettes, MA, USA),
rabbit anti-14-3-3E polyclonal antibody (1:500, Abgent, San
Diego, CA, USA) and mouse anti-actin monoclonal antibody
(1:2000, Sigma). Blots were then incubated with HRP-conjugated
rabbit anti-goat IgG (1:2000, Immunology Consultants Laborato-
ry, Newberg, OR, USA), HRP-conjugated goat anti-chicken IgY
(1:1000, Immunology Consultants Laboratory, Newberg, OR,
USA), HRP-conjugated goat anti-rabbit IgG (1:2000, Sigma) or
HRP-conjugated goat anti-mouse IgG (1:2000, Sigma) for 1 h at
room temperature and then visualized using chemiluminescence
(Pierce Biotechnology, Rockford, IL, USA).
Confirmation of binding between SB and EGFR in vitro
with Surface Plasmon Resonance (SPR) Biosensor analysis
The binding affinity of SB to integrin a2b1 in vitro was assayed
by the Drug Discovery and Design Center, Shanghai Institute of
Materia Medica, Chinese Academy of Sciences using a SPR-based
Biacore 3000 instrument (Biacore AB, Rapsgatan 7, S-754 50
Uppsala, Sweden) as reported before [30,31]. The recombinant
rat integrin a2 I domain (residues Pro138–Gly334) was expressed
as a His- (C-terminal) and Strep-fusion (N-terminal) protein using
Escherichia coli, and purified by affinity chromatography. The a2-I
domain gene incorporating KpnI and SacI sites was synthesized by
Shanghai Difa-Bio Ltd. (Shanghai, China). The KpnI-SacI
fragment of the a2-I domain gene was subcloned into pET-51b
expression vector (Novagen) and transformed into E. coli
BL21(DE3) strain (Novagen). The BL21 transformants were
cultivated in LB medium with ampicillin to an A600 nm of 0.8
at 37 uC, induced by adding isopropyl b-D-thiogalactopyranoside
(IPTG) to a final concentration of 0.005 mM, and incubated
overnight at 20 uC. The fusion protein, containing His-tag and
Strep-tag, was isolated from bacterial lysates by Ni
2+-chelation
affinity chromatography using a HiTrape
TM Chelating HP
column (GE Biosciences). The isolated protein was further purified
using Introductory Strep-Tag II Kit (Novagen). This step
improved purity of fusion protein to more than 95% (SDS-page
analysis), and ensured the integrity of polypeptide. The purified
recombinant a2-I domain was dialyzed against PBS buffer (KCl
2.7 mM, KH2PO4 1.5 mM, NaCl 136.9 mM, Na2HPO4
8.1 mM). Finally, the dialyzed protein solution was concentrated
to more than 1 mg/ml for SPR analysis. In SPR analysis, the
protein was dissolved in coupling buffer (10 mM sodium acetate,
pH 3.5) and immobilized onto a CM5 sensor chip as ligand in
6171 RU with N-ethyl-N9-(3-dimethylaminopropyl) carbodiimide
(EDC) and N-hydroxysuccinimide (NHS) according to the
standard primary amine-coupling procedures. Biacore data were
collected at 25 uC with HBS-EP buffer (10 mM HEPES, 150 mM
NaCl, 3 mM EDTA, 0.005% (v/v) surfactant P20, pH 7.4) as the
running buffer at a constant flow of 20 ml/min. SB was serially
diluted into the running buffer with final concentrations of 16.8,
24, 34.3, 49, 70 and 100 mM. The SB samples were injected into
the channels at a flow rate of 20 ml/min with injection time of 1
min, dissociation time of 2 min and followed by washing with the
running buffer for 2 min at 30 ml/min. The binding responses
were recorded continuously in response units (RU). The
equilibrium dissociation constant (KD) was determined by analysis
of the sensorgram-curves obtained at different concentrations of
SB by use of BIA evaluation software version 3.1 (Biacore) and the
1:1 Langmuir binding fitting model. The curve fitting efficiency
was evaluated by statistical parameter Chi
2.
Certification of binding affinity of SB to integrin a2b1 ex
vivo in platelets
The binding affinity of SB towards integrin a2b1 on platelets
was determined by checking the influence of SB on binding
between integrin a2b1 and its specific FITC-conjugated antibody.
Washed platelets were suspended in Ca2+ and Mg2+ free
Dulbecoo’s phosphate-buffered saline and then treated with
100 mM SB, FITC-conjugated mouse anti-CD49b monoclonal
antibody (1:200, BD Pharmingen) or cotreatment of antibody and
100 mM SB for 10 min. After washes with PBS, FITC fluorescence
was measured using the Becton Dickinson FACScan flow
cytometer (Becton Dickinson, La Jolla, CA, USA). The mean
fluorescence intensity of at least 10, 000 of platelet was analyzed by
Cellquest software (version 3.2).
Checking the effects of SB on platelets with or without
pre-treatment of antibody against integrin a2b1
Washed platelets were suspended in Ca
2+ and Mg
2+ free
Dulbecco’s phosphate-buffered-saline and then incubated for 10
min with 25, 50, 100 mM SB or 100 mM SB with pre-treatment of
FITC-conjugated mouse anti-CD49b monoclonal antibody (1:200,
10 min). The protein levels of coronin-1 B, hsp70 and p-hsp70 in
platelets were checked using Western blotting as described above.
The intracellular Ca(2+) level as well as ROS level, cell size were
checked using flow cytometry assay. Briefly, after twice PBS washes,
plateletswereincubatedwith 5 mM Fluo-3-AM(formeasurementof
the Ca(2+)) or 100 mM2 979-dichlorodihydrofluorescein diacetate
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PBS, fluorescence was measured using the Becton Dickinson
FACScan flow cytometer (Becton Dickinson, La Jolla, CA, USA).
The FSC (forward light scatter), correlating with cell size, was also
checked in platelets. Data were collected and the mean fluorescence
intensity of at least 10, 000 of platelet was analyzed by Cellquest
software (version 3.2).
Scanning electron microscopic examination
The scanning electron microscopic examination was conducted
similar to previous report [32]. Briefly, after treated with 100 mM
SB or natural saline for 10 min, platelets were fixed with 2%
glutaraldehyde for 30 min. After twice washes in distilled water,
the fixed platelets were layered on poly-L-lysine (1 mg/ml, MW
60,000) coated cover slips and allowed to settle in a humidified
chamber for 12 h at 4 uC. Then, the specimens were post-fixed in
1.0% osmium tetroxide in phosphate buffer (pH 7.4) for 2 h,
dehydrated with graded ethanol solutions and then evaporated in
a critical point apparatus. The specimens were then mounted on
aluminum copper stubs, and coated with 20 nm gold in a sputter
coater (HCP-2 model, Hitachi, Tokyo, Japan). Observations were
made with an environmental scanning electron microscope (XL-
30 model, Philip, Eindhoven, Netherlands).
Statistical analysis
For proteomic analysis, paired (control and SB-treated) protein
samples from 3 independent experiments were analyzed. And, for
each pair of protein samples, triplicate electrophoreses were
performed to ensure reproducibility. For other analysis, results
from at least 3 independent experiments were used for statistical
analysis. Data are expressed as mean 6 SD. Statistical significance
was evaluated with the non-paired Student’s t-test for comparison
between 2 means. Probability values ,0.05 were considered as
significantly different.
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